NCT00765024View on ClinicalTrials.gov

Ivermectin Versus Albendazole for Chronic Strongyloidiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Chronic Strongyloidiasis
Interventions
DRUG

Ivermectin

single dose of 200 mcg/kg

DRUG

ivermectin

two single dose of 200mcg/kg in 2 weeks

DRUG

Albendazole

Albendazole 7 days

Trial Locations (1)

10700

Siriraj Hospital, Bangkoknoi

Sponsors

Collaborators (1)

Atlantic Laboratory Ltd
All Listed Sponsors
collaborator

Atlantic Laboratory Ltd

UNKNOWN

lead

Mahidol University

OTHER